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1.  INTRODUCTION
With the advancement of microbial techniques and 
genetic engineering, the risk associated with the development 
of ‘superbugs’ (microbes that are difficult to diagnose or treat) 
and their deliberate use has increased many folds. Broadly, 
such an act is termed as ‘bioterrorism’ and can be used to 
target human, animal and agroecosystem of a competitor 
or enemy state. Biological agents that can be used for such 
purposes are collectively termed as biothreat agents or threat 
agents or select agent. These are extremely infectious and 
pathogenic microbes (bacteria, viruses and fungi). The resultant 
epidemic by the dissemination of these agents may cause mass 
mortality, morbidity of human, animals or plants, leading to 
serious socio-economic crisis. These agents could be spread 
through contamination of air (artificial aerosolisation), water 
(rivers, lakes and water reservoirs), soil, plants (food sources), 
animals, humans or even through currency. Metro cities with 
high population density, high rise buildings with poor or 
closed hypoventilation system, large transportation system and 
important monuments can be an easy target for terrorist. 
The Centres for Disease Control and Prevention 
(CDC) USA and NIAID have categorised the threat agents/
pathogens in to three categories based on pathogenicity 
and communicability1-2. Group A contains dangerous toxin 
producing microbes that can cause severe illness or death. The 
microorganism in this group can easily be transmitted from 
person to person and can lead to national disaster or epidemic. 
Other group B microbes are at second priority as these may 
also cause moderate morbidity and mortality. However, 
microbes which are presently not dangerous pathogens but 
have a potentiality of pathogenicity on bioengineering are 
kept under category C. This category also requires an attention 
as these may be used by a group of terrorist or individual to 
attack in near future by immoral manipulation through genetic 
engineering.
According to the prediction of Bassetti et al. 2017, 
antibiotic resistant will result in 10 million deaths per year by 
20503. Therefore, development of new class of antimicrobials 
or antibacterial needs a major strategic shift. The dearth of 
drugs to target specific bacteria especially multidrug resistance 
has led to the re-emergence of phage therapy. In such situations, 
phages can be employed as a potential agent for biocontrol 
of MDR organisms. Using phage against potential biothreat 
agents is specific, effective and harmless to humans and its 
environment. Their hunting nature for specific bacteria makes 
them important against bacterial bioagents. The time line of 
bacteriophage discovery has been shown in (Fig.1). 
Phages are abundantly present in diverse forms to monitor 
and control the population of dominating bacteria including 
the cyanobacteria, archaebacteria, and mycoplasmas, in 
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Figure 1. A time line of bacteriophage discovery.
Figure 2. Schematic representation of lytic and lysogenic cycle of 
bacteriophage.
astronomical figures; approximately 1031 different 
types of bacteriophages are estimated to be present on 
earth that maintains populations of various bacteria 
in different ecosystems5. All phage (s) are classified 
on the basis of a number of criteria including host 
specificity, nucleic acid type, morphology, mode 
of infection, morphogenesis, phylogeny, serology, 
sensitivity to physical and chemical agents, and 
their environment6. The recent update of the phage 
classification is available at the ICTV website 
and recent literature has also mentioned the newly 
classified phages (http://www.ictvonline.org/
virusTaxonomy.asp)7. Moreover, some important 
bacteriophages against extreme pathogens like 
B. antracis, B. cereus, Y. pestis etc have also been 
reported and isolated from various sources like 
infected animals and worms8-9 rodents and soil of 
decomposed carcass10-11 bovine milk, urine and 
excreta12, patients body fluid13, soil14. Apart from 
mentioned sources, sewage water is also a potential 
source for spreading biothreat agents15-17, and 
contains varieties of microbes and bacteriophages. 
Presently somatic coliphages are being used as 
indicator of water contamination which mostly 
infects members of Enterobacteriaceae family. These 
indicators may belong to Siphoviridae, Myoviridae, 
Podoviridae, and Microviridae families6. However, 
their activity may be affected by the factors like host 
bacterial density, pH and temperature of the medium, 
presence of varied ions, heavy metals and organic 
matters. Wastewater treatment plants use a number 
of antibiotics like trimethoprim macrolides, beta-
lactams, sulfonamides, tetracyclines and quinolones 
which provides a conducive environment for 
developing antibiotic resistance through horizontal 
gene transfer phenomenon among different 
microorganisms18-19 .
Also, some bacteriophages have also been 
isolated and enriched from bacterial cultures of 
biothreat bacteria for example, anthrax phages 
isolated from the culture of B. anthracis20 and B. 
cereus21. Similarly, Brucella has been isolated from 
B. abortus22, B. suis23 and B. melitensis culture 
respectively24. Most of the bacteriophages against 
biothreat agents belong to the order Caudovirales 
of tailed viruses, which is further subdivided into 
five families, namely Myoviridae, Podoviridae, 
Siphoviridae, Tectiviridae, and Inoviridae, reviewed 
in Filippov et al. (2013)2.For instance, Gamma phage 
(𝛾), Fah, Giraffe, F7, F9 and vB_BanS_Tsamsa 
belongs to Siphoviridae family and other phage 
like AP50, Worm intestinal phage1 (Wip1) are from 
Tectiviridae. Moreover, these bacteriophages have 
yielded positive results in identification, typing and 
bio control of anthrax25. Further, Y. pestis phages have 
also been reported from Podoviridae, Myoviridae, 
Siphoviridae2. The bacteriophage action against 
potential biothreat agents like B. anthracis, B.cereus, 
can impart a positive response on preparedness to 
  such eventualities.
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2.  LYTIC BACTERIOPHAGES ARE ACTUAL 
PREDATORS
Bacteriophages recognise specific receptors present on its 
host and get attached to it. Once it’s attached to the bacterium, 
phages inject their nucleic acid into the host cell. Thereafter, 
depending upon the mode of replication, phage undergoes 
either lytic or lysogenic cycle. The main step involved in phage 
multiplication are phage adsorption on host cells, penetration of 
phage nucleic acid, DNA replication followed by intracellular 
assembly of virions and finally release of phage particles after 
lysis of bacterial cell (Fig. 2). On entering lytic cycle, phage 
uses its host cellular machinery including protein-synthesis and 
energy-generating systems. The resultant of lytic cycle is the 
release of progeny with lysis of bacteria6 whereas; in lysogenic 
cycle nucleic acid gets integrated in to host, and is propagated 
with the host genome thereafter. This dormant phase is termed 
as the prophage stage and multiplies along with genetic 
material of the host26. On sensing and encountering adverse 
environment, the prophage stage enters in to lytic cycle and 
result in killing of bacteria. Therefore, phage or phage-derived 
enzymes can be a useful tool for treating antibiotic resistance 
bacteria27. This review is focused on biothreat agents, their 
detection and decontamination methods with special emphasis 
on bacteriophage therapy to target bacteria mainly multidrug 
resistance bacteria as a bio threat agent.
3.  MULTI DRUG RESISTANCE BACTERIA: AS 
A NEXT GENERATION BIOWEAPON 
Accumulating evidences clearly indicate that in the 
contemporary world, different microbes are becoming resistant 
to various antibiotics. Of these, some potential biothreat agents 
such as Y. Pestis, B. anthracis and some Brucella isolates have 
recently been found to be resistant to various antibiotics28, 
29-31. Presently, medical practitioners are facing a problem 
of emergence of multidrug bacteria (MDR) or ‘super-bugs’ 
which may lead to global health crisis in near future. Due 
to the advent of MDR bacteria, efficiency and reactivity of 
common antibiotics are declining hastily and consequently, 
leading to prolonged illness along with high risk of mortality. 
Further, a report from WHO also raise concern about high 
resistance in bacteria, to name a few, Escherichia coli for 
cephalosporin and fluoroquinolones, Klebsiella pneumonia 
for cephalosporin and carbapenems, Staphylococcus aureus 
for methicillin, Streptococcus pneumonia for penicillin, Non 
typhoidal Salmonella for fluoroquinolones, Shigella species for 
fluoroquinolones, Neisseria gonorrhoeae for cephalosporin, 
and Mycobacterium tuberculosis for rifampicin, isoniazid, and 
fluoroquinolone32. In the recently years, New Delhi metallo-
betalactamase-1 (NDM-1) gene responsible for resistance to 
a broad range of beta-lactam antibiotics has been identified 
globally33. The risk associated with these MDR bacteria is 
outbreak of disease which could be potentially even more 
devastating and lethal to populace. Terrorist groups may exploit 
such MDR bacteria as biothreat agents for their nefarious 
operations. Apart from naturally evolving MDR bacteria, 
manipulation of pathogenic organism by genetic engineering 
is another strategy to weaponise biological agents.
4.  BRIEF HISTORY OF BIOTHREAT ATTACK
Since ancient times, biological entities have been used 
in biological warfare to siege enemy assets of to force the 
enemy to surrender. History of contaminating water and food 
sources, hiding of pathogen infected cadavers and infection 
of live stock with potential biothreat agents were commonly 
practiced34. Though unverified, accounts of use of biothreat 
agents during two World Wars in the last century are there. In 
1925, immediately after World War I, the League of Nations 
formulated Geneva Protocol to discourage the use of chemical 
and biological weapons in warfare. Despite such efforts, some 
countries continued research in weaponizing biological agents, 
which were used later during World War II. The horrible 
accounts of the Japanese military Unit 731’s bioweapons 
experiments and field testing of these weapons on Chinese 
populations is well documented. It is estimated that during such 
experiments several thousand deaths occurred in China, due to 
dissemination of plague, typhoid, cholera, anthrax and other 
biothreat agents34-35. Subsequently, in 1972, the Biological 
Weapons Convention (BWC) treaty was established. A total of 
162 nations agreed for restricted development, production and 
stockpiling of biothreat based weapons. However, the violation 
of this treaty was reported in 1979, when an accidental aerosol 
discharge of anthrax spores took place at Sverdlovsk weapons 
site, which resulted in a death of a number of inhabitants by 
inhalational of anthrax downwind from the plant.
Since then, several incidences of biothreat attack have 
been reported. Of these, in United States ‘Rajneeshee bioterror 
attack’ is another example, which was attempted to swing an 
election in favour by Rajneesh cult. In 1984, in Dalles Oregon, 
751 individuals suffered from food poisoning due to deliberate 
contamination of food, particularly the salad was contaminated 
with Salmonella typhimurium at ten local restaurants36,37. 
Similarly, aerosolised Bacillus anthracis was deliberately used 
by Aum Shinrikyo in Tokyo, Japan in 199338. In Florida, after 
three weeks of September 11 2001 al-Qaida attacks, a rare 
disease of pulmonary anthrax was detected. It was suspected 
that anthrax was planned to be spread via postal distribution. 
However, other cases of anthrax took the attention of doctors, 
and with intensive care and medication, the situation was 
controlled28. Since then, various disease controlling authorities 
are strictly monitoring these agents. 
Apart from above mentioned cases, a number of 
incidences of agro-terrorism were also documented. This form 
of bioterrorism includes deliberate use of biological agent to 
infect economically important plants, staple & horticulture 
crops, farm animals, livestock and processed food. The purpose 
of agroterrorism is to spread contagious diseases through 
the food supply to create havoc, risk internal security, cause 
economic damage etc. Countries like Russia (1935-1992) 
and US (1943 to 1969) are supposed to have weaponised a 
variety of agroterrorism agents including the African swine 
fever virus, avian influenza virus, B. anthracis, Brucella 
spp., Burkholderia mallei, Chlamydophilapsittaci (causing 
psittacosis), FMD virus, Mycoplasma mycoides, newcastle 
disease virus, Orf virus, rinderpest virus, Venezuelan Equine 
Encephalitis virus, vesicular stomatitis virus etc. Apart from 
mentioned biothreat agents other plant pathogenic viruses like 
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potato virus y, tobacco mosaic virus, wheat and barley streak 
mosaic virus, and fungi Magnaporthe grisea, Puccinia sorghi 
and Puccinia graminis  etc. have been listed as potential agro-
threat agents39-40. Based on available literature and reports39-
41the strategic contamination incidences on agroterrorism 
reported are as follow:
During World War I, Anton Dilger, a German-American • 
physician, injected or added pathogen (Dilger’s agents) 
into the horses prior to export to Europe.
In 1943, UK during WWII Richard Ford, (British • 
naturalist), charged Germany for damaging crop by 
dropping insect pest of potatoes (Colorado Potato 
Beetles). 
In 1952, Kenyan nationalists associated with Mau • 
Mau movement poisoned 33 cattle at a British mission 
station by applying latex of African milk bush plant 
(Synadeniumgrantii).
In 1985, the USDA charged Mexican contract workers for • 
dissemination of screwworm (Cochliomyiahominivorax) 
among livestock. 
In 2000, Palestinian media reported that Israeli settlers • 
from the Efrat settlement on the West Bank Israel, 
released sewer water into Palestinian agricultural fields in 
the village of Khadder, Israel which burdened farmer by 
loss of approx. 5,000 dollars. 
In the context of nations based on agriculture, such as 
ours, where majority of the population is directly or indirectly 
dependent upon agriculture for their earning and survival, such 
attacks can significantly damage the rural socio-economic 
structure and at national level, can affect GDP of country. 
5.  DETECTION AND MONITORING OF BIOTHREAT 
AGENTS
Increase in threat of bio warfare agents indicates an 
impending danger at global level. Therefore, there is an urgent 
need to emphasise on faster detection and identification system 
to timely detect biothreat agents42. In this regard, CDC have 
formulated structured guidance for the detection, diagnosis, 
and reporting of biological threat agents (http://www.
bt.cdc.gov/lrn/factsheet.asp). Although different advanced 
detection systems are currently being used for detection and 
identification, most of them have certain limitations, which 
include sensitivity and specificity issues, limited application 
in field conditions, false negative results etc. In Annexure I, 
we have detailed various detection system, compiled from 
comprehensive review of available technologies and system 
detect biothreat agents42-44. Although subsequent advancement 
in technologies have simplified and shortened the process by 
replacing many cumbersome steps, false positive result due to 
cross contamination and interfering agents still exist. 
An efficient detection system for countering biothreat 
agents is expected to have following features:
Ability to detect multiple biothreat agents simultaneously• 
Accuracy in identification of biothreat agents and/or its • 
components
Should be portable and light weight with capability of • 
deployment in field conditions
high sensitivity and specificity to detect biothreat agents • 
even at low levels 
Ability to detect recombinants or modified organisms • 
Should use non-destructive technology, so that collected • 
specimens can be further analysed in laboratories
6.  AVAILABLE BIOTHREAT DECONTAMINATION/ 
DISINFECTION STRATEGIES AND THEIR 
LIMITATIONS
The real challenge after detection of biothreat agents is its 
decontamination or inactivation. Since it is nearly impossible to 
develop a single system to safeguard against all types of biothreat 
agents, developing advance methods of decontamination 
and treatment can help in countering the actual situation of 
bioterrorism. The term “disinfection” encircles physical or 
chemical control of microorganisms and does not necessarily 
imply complete destruction of all microorganisms45. Among 
the physical methods, heat inactivation, irradiation sterilisation 
(e.g., electron beam, gamma, or UV light and ozone), 
quarantines, and proper disposal of infected carcasses (National 
Research Council, 2002) are important. On the other hand, use 
of chemicals and drugs like free chlorine, monochloramine, 
chlorine dioxide, methyl bromide for fumigation, high or low 
pH, pH-amended bleach, activated peroxide, atropine, amyl 
nitrite, and thiosulfate etc. have been utilised since long for 
decontamination of air, water or equipment. However, the main 
drawback of chemical decontamination is that after a certain 
period, microorganisms may develop resistance to certain 
chemicals and drugs. Besides, excessive use of certain chemical 
is destructive to environment since most of these chemicals are 
corrosive and toxic to nature46. Of these, some decontaminants 
like MeBrvapor is dangerous to human health. However, some 
newly developed products for decontamination are being 
developed that are suggested as non-toxic and environmentally 
friendly. The “L-Gel” (mild commercial oxidiser, fumed 
silica gelling agent, Cab-O-Sil Eh-5) has been evaluated for 
decontamination efficiency against chemical warfare agents 
and various biological warfare agents as well47. 
Apart from physical and chemical methods, biological 
methods like prophylactic vaccines, broad spectrum antibiotics, 
antiviral drugs and antibodies are comparatively more specific 
and have a targeted approach to cater the need of neutralisation 
effect of pathogens. however, the irony is, to develop a new 
biological weapon 1 to 3 years is needed while discovery or 
raising a new drug or vaccine needs 8 to 10 years to develop48 
(Institute of Medicine and National Research Council, 2002). 
Nevertheless, with the advancement in the bioinformatics tools 
and genome sequencing platforms, this process has gained 
momentum and by targeting the immunogenic components of 
biothreat agents, recently, epitope-based vaccine or protein-
based vaccines are being designed to trigger protective immune 
response against emerging pathogen49. Although the protein-
based vaccines gave a new way to be used as alternative to 
the whole pathogen in vaccine development, certain limitation 
lies with it, which includes physiological instability and 
immunogenicity50. In order to design an efficient delivery 
system, bacteriophages T4 capsid-based antigen delivery 
system was develop and tested against Bacillus anthracis 
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 Table 1. Decontamination methods of biothreat agents
Agent with examples Decontaminating agents
Blood Agent
(hydrogen cyanide, Cyanogen chloride)
Amyl nitrite, sodium nitrite and 4-dimethylaminophenol (DMAP), Amyl nitrite, Sodium thiosufhate 
(50 ml of 25% solution), hydroxocobalamin (vitamin B12a, 20 mg) and kelocyanor (cobalt-EDTA), 
disodium 2-ketoglutarate, Hyperbaric oxygen.
Choking Agent
(Phosgene, Chlorine, Cholopicrin) Cortisone (hexamethasone or beclamethasone) and sodium bicarbonate, codeine
Nerve Gas
(Sarin, Soman, Tabun, VX)
Enzymatic hydrolysis, atropine, a muscarinic receptor antagonist, an anticonvulsant (diazepam), 
cholinesterase reactivator (oxime).
Blister Agent
(Mustard Gas, Nitrogen mustrad1,2,3, 
Lewisite)
Diaphragm gas masks impregnated with efficient sorbent(Brophy et al., 1959). On exposure 









On exposure symptomatic and supportive  treatment (Centers for Disease Control and Prevention,  
CDC)
Biological Toxin
(Saxitoxin, Ricin, Botulinum toxin A, 
Staphylococcal enterotoxin B)
Saxitoxin: Symptomatic and supportive treatment, catharsis (vomiting or purging) is recommended 
Centers for Disease Control and Prevention (CDC). Ricin: Symptomatic and supportive treatment, 
candidate vaccines and ricin inhibitors (eg, pteroic acid, neopterin, pterin tautomer, and guanine 
tautomer.  Centers for Disease Control and Prevention (CDC).
Botulinum toxin A: Symptomatic and supportive treatment, antitoxin that obstruct the action of 
neurotoxin circulating in the blood. The trivalent antitoxin (effective against three neurotoxins: A, 
B, and E) provided by Centers for Disease Control and Prevention (CDC).
Staphylococcal enterotoxin B:Symptomatic support, recover with active hydration and supportive 
measures and  neutralization of SAgs of S. aureus by monoclonal Abs (MAbs)84
Virus
(Small pox, Ebolahemmhagic fever , 
Venezuelan equine encephalitis)
Small pox: Symptomatic and supportive treatment, Tecovirimat,Cidofovir and Brincidofovir 
(Centers for Disease Control and Prevention)
Ebolahemmhagic fever: Symptomatic and supportive treatment (Centers for Disease Control and 
Prevention)
Venezuelan equine encephalitis: Symptomatic and supportive treatment most likely involves 
correcting fluid deficiencies (Centers for Disease Control and Prevention)
Rickettsia and Q fever
Rickettsia:  Chloramphenicol and Tetracycline (Drugs of choice) (CDC)
Q fever: Treated with a combination of antibiotics including doxycycline and hydroxychloroquine 
for several months (CDC)
Bacteria
Anthrax, Plaque, Brucellosis
Anthrax : CDC has issued Emergency Use Instructions (EUI) for doxycycline and ciprofloxacin for 
post-exposure prophylaxis (PEP) of anthrax
Plaque: Commonly available antibiotics (Streptomycin, Gentamicin, Levofloxacin, Ciprofloxacin,D
oxycycline,Moxifloxacin,Chloramphenicol)
Brucellosis: Doxycycline and rifampinorAzithromycin and Gentamicin  in combination85 ( Centers 
for Disease Control and Prevention , CDC)
which successfully elicit both humoral and cellular immune 
responses without any adjuvant50. Table 1 has listed some of the 
biothreat agents and their existing decontamination methods. 
7.  P R O P H Y L A C T I C  A N D  T H E R A P E U T I C 
APPLICATION OF BACTERIOPHAGE AGAINST 
MULTIDRUG RESISTANT BACTERIA
Soon after its discovery by Twort & d’herelle in the early 
1900s, phage particles became a potent tool for treating infections 
and wounds. However, with the discovery of antibiotics in 
1928, phage therapy suffered a setback due to comparatively 
quicker effects of antibiotics. Since then, antibiotics have been 
used extensively and often indiscriminately in various fields 
resulting in the development of resistance against various 
drugs along with several side-effects. however, scientists in 
erstwhile Soviet Union and Eastern Europe continued with their 
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phage therapy trials and published their results in non-English 
(primarily Russian, Georgian, and Polish) journals. hence, 
western researchers remained unaware from these findings51. 
Unlike antibiotics, phages posses’ unique characteristic of 
targeting specific bacteria, which can be employed in a wide 
variety of applications, including biotechnology, biosensor, 
therapeutic medicine, food preservation, aquaculture diseases, 
pollution remediation, and wastewater treatment. 
There is an urgent need to plan and develop effective 
strategies to mitigate potential biothreats. This may include 
rapid detection and diagnosis, technology for fast information 
circulation, vaccine development and implementation of control 
measures at point of care27. Understanding the basic mechanism 
and mode of infection of biothreat agents will provide an 
appropriate solution for development of prophylactic measures, 
and the dose of such prophylactic alternatives can be optimised 
once the pathogenicity level of the threat agent is known. 
Moreover, with biotechnological advancements, developing 
hybrid vaccines (subunit or chimeric) have now become more 
feasible. Also these vaccines are more effective with lesser side 
effects than injecting whole attenuated pathogen52-54. Therefore, 
cutting edge technologies can be employed to target pathogens 
by displaying antigen which may stimulate either innate 
immune responses or adaptive immune responses55 depending 
up on the type of biothreat agent. Recently, bacteriophages 
like lambda, M13 and T4 were used to display antigen56-58.For 
example Tao et al.,58 developed multivalent vaccines by fusing 
capsid proteins of T4 bacteriophage with anthrax-plague 
antigens. 
With the help of bacteriophages, potential pathogens can 
be destroyed. A number of phages against MDR P. aeruginosa, 
Salmonella and extended spectrum beta-lactamase Escherichia 
coli and Klebsiella pneumonia have also been isolated59. 
Immense potential of this therapy in treating fatal superbug 
infections has recently been demonstrated in a 68-year-old 
diabetic patient with necrotizing pancreatitis, infected with 
MDR “Iraqibacter’’ Acinetobacter baumannii. The patient 
was given a cocktail of nine bacteriophages intravenously and 
percutaneously into the abscess cavities, and after few days of 
treatment the patient awoke from coma and gradually returned 
to normal health60.The other case of antibiotic failure on MDR 
bacteria took place in Pittsburgh, where a young girl with 
cystic fibrosis was about to be administered a phage therapy 
but unfortunately, due to delay in phage matching and other 
protocols, the girl died (https://www.statnews.com/2017/11/28/
phage-therapy-mallory-smith). By and large, phage library 
preparation against probable biothreat agents along with MDR 
bacteria can be one of the options for saving lives and to 
mitigate biosecurity related issues in near future. 
8 .  B A C T E R I O P H A G E  A P P L I C AT I O N  I N 
AGRICULTURE AND FOOD SAFETY 
Contaminated food is one of the major sources of 
emergence of food borne pathogens, that cause diarrhoea, 
and in acute conditions, and may also lead to kidney and 
liver failure, neural disorders, reactive arthritis, cancer and 
in some cases, even death (http://www.who.int/foodsafety/
areas_work/foodborne-diseases/en/). According to the CDC 
USA, millions of people suffer annually due to intake of 
contaminated food with known pathogens and unspecified 
agents. Although some pathogens have been listed by the CDC, 
that contributes to domestically acquired food borne diseases 
for example Salmonella, non-typhoidal, Campylobacter spp., 
E.coli (STEC) O157, Listeria monocytogenes (https://www.
cdc.gov/foodborneburden/2011-foodbornestimates.html). 
Similarly, other pathogens like Clostridium spp., Shigella spp. 
and Vibrio spp. are also a cause for illness, hospitalisations, 
and deaths61. It is important to realise that, food is susceptible 
to pathogen attack at different stages starting from growth or 
production, packaging and storage till reaching the plate. This 
susceptibility increases in case of ready-to-eat-products, dairy 
products and meat-based product that are also consumed by 
armed forces due to their operations/posting at distant and 
difficult terrains. however, naturally occurring phage(s) present 
in food products provide protection to these products to certain 
extent62,63. In addition, some pathogens cover themselves by 
biofilms thereby limiting the action of antimicrobial agents64. 
Similarly, crops are also vulnerable to bioattack that can disturb 
and affect a large portion of population. Bacterial infestation in 
agricultural field decrease yield which in turn lead to serious 
economic consequences65. Shift from antibiotic application to 
phage application has been demonstrated to yield interesting 
results in vegetables like tomato, citrus and onion, where phage 
has been applied to treat bacterial infections66,67. Moreover, few 
phage products named Agri PhageTM, Omnilytics, LISTEX, 
Listshield™, and Intralytix have also been approved by the 
USFDA and are commercially being used for food safety68. 
Previously, phage therapy has been employed at various stages 
of food processing to restrict the growth of pathogens on 
food66.
9.  B A C T E R I O P H A G E  A P P L I C AT I O N  I N 
DIAGNOSTIC TECHNOLOGIES 
Phage (s) are considered as a biotechnological tool due to 
their simple structure and small nucleic acid content. Presently, 
for detection of biothreat agents various microbiological 
methods and biotests are being used. However, these methods 
take several hours to days for completion. Hence, real-time 
detectors or fast diagnostic methods are urgently needed 
to detect the presence of bioagents69. A new approach of 
fast detection includes use of phage antibody i.e., phage 
recombinants that display specific antibodies against a particular 
antigen. These phage antibodies can further be tagged with 
markers or fluorescent dye for quick and easy detection70. In 
addition to these, phage derived probes have been successfully 
used for detection of B. anthracis spores and S. typhimurium 
cells69,71. With latest discoveries and advancement in the 
field of biotechnological, phage therapy can be customised 
for targeting its host Fig. 3. For example, enzyme endolysin 
that is responsible for lysis of bacteria in bacteriophage can 
be over expressed in vitro, purified for direct administration, 
instead of using whole phage. Other use of biotechnology in 
phage therapy is to genetically modify phage for delivering 
specific molecules acting as antimicrobials73. Likewise, phage 
display technique is also a unique approach for synthesising 
polypeptides with novel characteristics. The concept of phage 
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display is to express protein over the surface of phage particle, 
formed by fusing DNA that encodes the polypeptide with coat 
protein gene74. Phage’s like M13, lambda and T7 are being 
used for phage display technique. The peptide displayed over 
phage can be used for drug designing, mimicking as receptor, to 
create library of highly specific proteins and also as a curative 
agent by hampering receptor-ligand interaction74. 
preserving, antibacterial agent and efficient candidate for phage 
therapy against biothreat agents. Phage therapy can be a safe, 
efficient and natural alternative to drug resistance antimicrobial. 
It is thus important to identify emerging biothreat agents along 
with other MDR bacteria and to isolate their specific phages 
and to store them for their use when required.
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